Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 17/20 | 0.62 |
| ▸ | CTSL | P07711 | 9/20 | 0.61 |
| ▸ | CTSS | P25774 | 8/20 | 0.61 |
| ▸ | CTSB | P07858 | 4/20 | 0.61 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.57 |
| ▸ | CAPNS1 | P04632 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3577128 | 1.00 | CTSK (0.62) | CTSKCTSLCTSSCTSBCAPN1 | |
| SCHEMBL7514109 | 1.00 | CTSK (0.62) | CTSKCTSLCTSSCTSBCAPN1 | |
| SCHEMBL7525753 | 0.98 | CTSK (0.61) | CTSKCTSLCTSSCTSBCAPN1 | |
| SCHEMBL7515987 | 0.95 | CTSK (0.61) | CTSKCTSLCTSSCTSB | |
| SCHEMBL8811434 | 0.92 | CAPN1 (0.52) | CTSKCTSLCTSSCTSBCAPN1 | |
| SCHEMBL8811449 | 0.92 | CAPN1 (0.52) | CTSKCTSLCTSSCTSBCAPN1 | |
| SCHEMBL3592461 | 0.91 | CTSK (0.64) | CTSKCTSLCTSSCTSBCAPN1 | |
| SCHEMBL7514113 | 0.91 | CTSK (0.59) | CTSKCTSLCTSSCTSB | |
| SCHEMBL4621195 | 0.89 | CTSK (0.62) | CTSKCTSLCTSSCTSBCAPN1 | |
| SCHEMBL4622199 | 0.89 | CTSK (0.62) | CTSKCTSLCTSSCTSBCAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0925786-A1 | REMEDIES FOR ISCHEMIC DISEASES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-06-30 | — | — | EP | disclosed |
| EP-0810221-A1 | OXYGEN-CONTAINING HETEROCYCLIC DERIVATIVES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-12-03 | — | — | EP | disclosed |